{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:52:24Z","timestamp":1793332344548,"version":"4.5.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context:<\/jats:title>\n                    <jats:p>Rosuvastatin (RSV) is a new synthetic, hydrophilic statin with potent anti-inflammatory and osseodifferentiation actions. Autogenous bone graft (ABG) is still considered the gold standard in reconstructive bone surgery. Addition of platelet-rich fibrin (PRF) to ABG provides sustained release of various growth factors and facilitates survival of the graft.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>The study aims to clinically and radiographically compare the effectiveness of ABG and PRF with and without 1.2 mg RSV gel in the surgical treatment of intrabony defect in chronic Periodontitis patient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings and Design:<\/jats:title>\n                    <jats:p>This was a randomized controlled clinical trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects and Methods:<\/jats:title>\n                    <jats:p>Thirty-nine patients (one site per participant) with chronic periodontitis were randomly divided into three groups: Group 1 (open flap debridement [OFD] + placebo), Group 2 (OFD + ABG + PRF), and Group 3 (OFD + ABG + PRF + 1.2 mg RSV). Relative attachment level (RAL) and probing pocket depth (PPD) were recorded at baseline, 3, 6, and 9 months. Radiographic measurements such as defect height (A and B) and defect width (C) were calculated at baseline and 9 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>Intergroup comparison was done using Kruskal\u2013Wallis ANOVA. An intragroup comparison was done using Friedman test and Wilcoxon signed-rank test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The mean PPD reduction and mean RAL gain were highly significant in Group 3 and Group 2 than Group 1. For Group 3, a significant reduction of defect height and width and a significant amount of bone fill were achieved than Group 2 and Group 1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Addition of 1.2 mg RSV gel, PRF, and ABG has synergistic effects, explaining their role as a regenerative material in the treatment of intrabony defects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ccd.ccd_740_20","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T11:10:58Z","timestamp":1648033858000},"page":"69-77","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Comparative Evaluation of Autogenous Bone Graft and Autologous Platelet-Rich Fibrin with and Without 1.2 mg in situ Rosuvastatin Gel in the Surgical Treatment of Intrabony Defect in Chronic Periodontitis Patients"],"prefix":"10.4103","volume":"13","author":[{"given":"Kompal","family":"Gautam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setu","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Rizwan","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpana","family":"Shekhawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20240901","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1902\/annals.1996.1.1.821","article-title":"Periodontal diseases: Pathogenesis","volume":"1","author":"Offenbacher","year":"1996","journal-title":"Ann Periodontol"},{"key":"R2-12-20240901","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1600-051X.2005.00785.x","article-title":"Host response modulation in the management of periodontal diseases","volume":"32","author":"Salvi","year":"2005","journal-title":"J Clin Periodontol"},{"key":"R3-12-20240901","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1016\/S0024-3205(01)01363-7","article-title":"Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits","volume":"69","author":"Jeon","year":"2001","journal-title":"Life Sci"},{"key":"R4-12-20240901","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4103\/2230-8210.163106","article-title":"Pleiotropic effects of statins","volume":"19","author":"Kavalipati","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"key":"R5-12-20240901","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00005-009-0038-5","article-title":"Immunomodulation by statins: Mechanisms and potential impact on autoimmune diseases","volume":"57","author":"Chow","year":"2009","journal-title":"Arch Immunol Ther Exp (Warsz"},{"key":"R6-12-20240901","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1074\/jbc.M606706200","article-title":"Statin-induced Ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation","volume":"282","author":"Ghosh-Choudhury","year":"2007","journal-title":"J Biol Chem"},{"key":"R7-12-20240901","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2147\/DDDT.S10812","article-title":"Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective","volume":"4","author":"Kones","year":"2010","journal-title":"Drug Des Devel Ther"},{"key":"R8-12-20240901","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.bjp.0704070","article-title":"A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: The role of mevalonic acid","volume":"133","author":"Stalker","year":"2001","journal-title":"Br J Pharmacol"},{"key":"R9-12-20240901","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1006\/bbrc.2000.4232","article-title":"Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells","volume":"280","author":"Maeda","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"R10-12-20240901","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1902\/jop.2015.140631","article-title":"Efficacy of locally delivered 1.2% rosuvastatin gel to non-surgical treatment of patients with chronic periodontitis: A randomized, placebo-controlled clinical trial","volume":"86","author":"Pradeep","year":"2015","journal-title":"J Periodontol"},{"key":"R11-12-20240901","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/2231-0754.176247","article-title":"Autogenous bone grafts in periodontal practice: A literature review","volume":"8","author":"Pandit","year":"2016","journal-title":"J Int Clin Dent Res Organ"},{"key":"R12-12-20240901","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.tripleo.2005.07.012","article-title":"Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part V: Histologic evaluations of PRF effects on bone allograft maturation in sinus lift","volume":"101","author":"Choukroun","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R13-12-20240901","doi-asserted-by":"crossref","first-page":"418","DOI":"10.4103\/1735-3327.166188","article-title":"The use of platelet-rich fibrin (PRF) and PRF-mixed particulated autogenous bone graft in the treatment of bone defects: An experimental and histomorphometrical study","volume":"12","author":"K\u00f6kdere","year":"2015","journal-title":"Dent Res J (Isfahan"},{"key":"R14-12-20240901","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1902\/jop.2011.110075","article-title":"Treatment of 3-wall intrabony defects in patients with chronic periodontitis with autologous platelet-rich fibrin: A randomized controlled clinical trial","volume":"82","author":"Sharma","year":"2011","journal-title":"J Periodontol"},{"key":"R15-12-20240901","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1902\/jop.2002.73.10.1141","article-title":"Effects of simvastatin gels on murine calvarial bone","volume":"73","author":"Thylin","year":"2002","journal-title":"J Periodontol"},{"key":"R16-12-20240901","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1902\/jop.2016.160015","article-title":"Platelet-rich fibrin with 1.2% rosuvastatin for treatment of intrabony defects in chronic periodontitis: A randomized controlled clinical trial","volume":"87","author":"Pradeep","year":"2016","journal-title":"J Periodontol"},{"key":"R17-12-20240901","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1902\/jop.2015.150131","article-title":"Rosuvastatin 1.2 mg in situ gel combined with 1:1 mixture of autologous platelet-rich fibrin and porous hydroxyapatite bone graft in surgical treatment of mandibular Class II furcation defects: A randomized clinical control trial","volume":"87","author":"Pradeep","year":"2016","journal-title":"J Periodontol"},{"key":"R18-12-20240901","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1902\/jop.2016.150706","article-title":"1.2% rosuvastatin versus 1.2% atorvastatin gel local drug delivery and redelivery in treatment of intrabony defects in chronic periodontitis: A randomized placebo-controlled clinical trial","volume":"87","author":"Pradeep","year":"2016","journal-title":"J Periodontol"},{"key":"R19-12-20240901","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tripleo.2006.03.010","article-title":"Maxillary sinus floor augmentation using autogenous bone grafts and platelet-enriched fibrin glue with simultaneous implant placement","volume":"103","author":"Lee","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R20-12-20240901","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4103\/0976-237X.169850","article-title":"Platelet concentration in platelet concentrates and periodontal regeneration-unscrambling the ambiguity","volume":"6","author":"Suchetha","year":"2015","journal-title":"Contemp Clin Dent"},{"key":"R21-12-20240901","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/0972-124X.145803","article-title":"Comparative evaluation of platelet-rich fibrin with demineralized freeze-dried bone allograft in periodontal infrabony defects: A randomized controlled clinical study","volume":"19","author":"Shah","year":"2015","journal-title":"J Indian Soc Periodontol"},{"key":"R22-12-20240901","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/0972-124X.148639","article-title":"Clinical and radiographic evaluation of nanocrystalline hydroxyapatite with or without platelet-rich fibrin membrane in the treatment of periodontal intrabony defects","volume":"19","author":"Elgendy","year":"2015","journal-title":"J Indian Soc Periodontol"},{"key":"R23-12-20240901","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/1305-7456.149653","article-title":"Evaluation of intrabony defects treated with platelet-rich fibrin or autogenous bone graft: A comparative analysis","volume":"9","author":"Mathur","year":"2015","journal-title":"Eur J Dent"},{"key":"R24-12-20240901","first-page":"363","article-title":"Gel local drug delivery and redelivery of rosuvastatin in the treatment of class II furcation defects","volume":"7","author":"Saliem","year":"2017","journal-title":"IJABR"},{"key":"R25-12-20240901","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1055\/s-0039-1688522","article-title":"Efficacy of locally administered 1.2% rosuvastatin gel in patients with periodontitis: A randomized placebo controlled clinical trial","volume":"13","author":"Chatterjee","year":"2019","journal-title":"Eur J Dent"},{"key":"R26-12-20240901","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.actbio.2009.09.027","article-title":"In vivo performance of absorbable collagen sponges with rosuvastatin in critical-size cortical bone defects","volume":"6","author":"Monjo","year":"2010","journal-title":"Acta Biomater"},{"key":"R27-12-20240901","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1902\/jop.2016.160384","article-title":"The effect of locally delivered statins on treating periodontal intrabony defects: A systematic review and meta-analysis","volume":"88","author":"Sinjab","year":"2017","journal-title":"J Periodontol"},{"key":"R28-12-20240901","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1365-2125.2005.02568.x","article-title":"Reduction of oxidative stress and modulation of autoantibodies against modified low-density lipoprotein after rosuvastatin therapy","volume":"61","author":"Resch","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"R29-12-20240901","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1159\/000322332","article-title":"Rosuvastatin promotes osteoblast differentiation and regulates SLCO1A1 transporter gene expression in MC3T3-E1 cells","volume":"26","author":"Monjo","year":"2010","journal-title":"Cell Physiol Biochem"},{"key":"R30-12-20240901","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jbspin.2012.07.007","article-title":"Rosuvastatin inhibits spontaneous and IL-1 \u03b2-induced interleukin-6 production from human cultured osteoblastic cells","volume":"80","author":"Lazzerini","year":"2013","journal-title":"Joint Bone Spine"},{"key":"R31-12-20240901","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/bcp.12564","article-title":"Pleiotropic effects of statins on the treatment of chronic periodontitis--A systematic review","volume":"79","author":"Estanislau","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"R32-12-20240901","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jdent.2017.08.011","article-title":"The effect of local and systemic statin use as an adjunct to non-surgical and surgical periodontal therapy-A systematic review and meta-analysis","volume":"67","author":"Bertl","year":"2017","journal-title":"J Dent"}],"container-title":["Contemporary Clinical Dentistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ccd.ccd_740_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:10:55Z","timestamp":1787166655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ccd.ccd_740_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ccd.ccd_740_20","relation":{},"ISSN":["0976-237X"],"issn-type":[{"value":"0976-237X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}